Evidence map›Paper›PMID 30955485›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2019

The rabbit papillomavirus model: a valuable tool to study viral-host interactions.

Nancy M Cladel, Xuwen Peng, Neil Christensen, Jiafen Hu

Open access · bronzeAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Analysis of Fibropapillomatosis in Roe Deer (Animals : an open access journal from MDPI · 2024
    Article
  4. Article
  5. Viral vector-based therapeutic HPV vaccines.Clinical and experimental medicine · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nancy M Cladel1 The Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine , Hershey, PA 17033 , USA.
Xuwen Peng3 Department of Comparative Medicine, Pennsylvania State University College of Medicine , Hershey, PA 17033 , USA.
Neil Christensen1 The Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine , Hershey, PA 17033 , USA.
Jiafen Hu1 The Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine , Hershey, PA 17033 , USA.
Pennsylvania State University · US

Funding

Papillomavirus Host InterationR01CA047622 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHRISTENSEN, NEIL D · 1988 to 2015
$3.8M
NCI NIH HHS R01 CA047622NIAID NIH HHS HHSN272201000020I
6 · The paper itself

Abstract

Cottontail rabbit papillomavirus (CRPV) was the first DNA virus shown to be tumorigenic. The virus has since been renamed and is officially known as Sylvilagus floridanus papillomavirus 1 (SfPV1). Since its inception as a surrogate preclinical model for high-risk human papillomavirus (HPV) infections, the SfPV1/rabbit model has been widely used to study viral-host interactions and has played a pivotal role in the successful development of three prophylactic virus-like particle vaccines. In this review, we will focus on the use of the model to gain a better understanding of viral pathogenesis, gene function and host immune responses to viral infections. We will discuss the application of the model in HPV-associated vaccine testing, in therapeutic vaccine development (using our novel HLA-A2.1 transgenic rabbits) and in the development and validation of novel anti-viral and anti-tumour compounds. Our goal is to demonstrate the role the SfPV1/rabbit model has played, and continues to play, in helping to unravel the intricacies of papillomavirus infections and to develop tools to thwart the disease. This article is part of the theme issue 'Silent cancer agents: multi-disciplinary modelling of human DNA oncoviruses'.

Indexed as

Host-Pathogen InteractionsAnimalsCottontail rabbit papillomavirusDisease Models, AnimalHumansPapillomaviridaePapillomavirus InfectionsRabbitsanti-viral treatmentDNA vaccineimmunizationinfectionpapillomavirusrabbit

Identifiers

PMID30955485
PMCPMC6501911
OpenAlexW2939895176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.